Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TEF
3876
DELISTED
Telefonica
TEF
| $420K | ﹤0.01% |
+36,938
| New | +$382K |
2013 Q3
0 quarters
|
|
|
FLG
3877
CALL
Flagstar Bank National Association
FLG
$4.86B
| $419K | ﹤0.01% |
9,233
+1,400
| +18% | +$62.9K |
2013 Q2
1 quarter
|
|
3878
Allegiant Air
ALGT
$2.12B
| $418K | ﹤0.01% |
3,969
-8,775
| -69% | -$867K |
2013 Q2
1 quarter
|
|
|
AMED
3879
PUT
DELISTED
Amedisys
AMED
| $418K | ﹤0.01% |
24,300
+3,900
| +19% | +$57.9K |
2013 Q2
1 quarter
|
|
3880
PUT
Ares Capital
ARCC
$13.5B
| $418K | ﹤0.01% |
24,200
-25,200
| -51% | -$441K |
2013 Q2
1 quarter
|
|
|
NGD
3881
PUT
DELISTED
New Gold Inc
NGD
| $418K | ﹤0.01% |
69,900
-4,300
| -6% | -$29.3K |
2013 Q2
1 quarter
|
|
|
DMND
3882
DELISTED
DIAMOND FOODS, INC.
DMND
| $418K | ﹤0.01% |
17,760
-7,984
| -31% | -$172K |
2013 Q2
1 quarter
|
|
|
STMP
3883
CALL
DELISTED
Stamps.com, Inc.
STMP
| $418K | ﹤0.01% |
9,100
-8,600
| -49% | -$360K |
2013 Q2
1 quarter
|
|
|
NIHD
3884
PUT
DELISTED
NII HOLDINGS INC CL B
NIHD
| $418K | ﹤0.01% |
68,800
-20,900
| -23% | -$141K |
2013 Q2
1 quarter
|
|
3885
CALL
Ball Corp
BALL
$14.9B
| $417K | ﹤0.01% |
18,600
-14,800
| -44% | -$332K |
2013 Q2
1 quarter
|
|
|
HBI
3886
PUT
DELISTED
Hanesbrands
HBI
| $417K | ﹤0.01% |
26,800
-31,200
| -54% | -$464K |
2013 Q2
1 quarter
|
|
3887
CALL
Nektar Therapeutics
NKTR
$1.49B
| $417K | ﹤0.01% |
2,660
+1,933
| +266% | +$357K |
2013 Q2
1 quarter
|
|
3888
TFS Financial
TFSL
$4.72B
| $417K | ﹤0.01% |
34,831
-84,996
| -71% | -$979K |
2013 Q2
1 quarter
|
|
|
TCO
3889
CALL
DELISTED
Taubman Centers Inc.
TCO
| $417K | ﹤0.01% |
6,200
+2,800
| +82% | +$201K |
2013 Q2
1 quarter
|
|
|
QIHU
3890
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $417K | ﹤0.01% |
5,012
-320,290
| -98% | -$22.5M |
2013 Q2
1 quarter
|
|
3891
Fulton Financial
FULT
$4.35B
| $415K | ﹤0.01% |
35,483
-172,960
| -83% | -$2.11M |
2013 Q2
1 quarter
|
|
3892
CALL
Public Service Enterprise Group
PEG
$33.9B
| $415K | ﹤0.01% |
12,600
+1,200
| +11% | +$39.7K |
2013 Q2
1 quarter
|
|
|
SGMO
3893
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $415K | ﹤0.01% |
39,600
-21,500
| -35% | -$214K |
2013 Q2
1 quarter
|
|
|
SNTS
3894
CALL
DELISTED
SANTARUS INC
SNTS
| $415K | ﹤0.01% |
18,400
-6,300
| -26% | -$150K |
2013 Q2
1 quarter
|
|
|
MCF
3895
CALL
DELISTED
Contango Oil & Gas Co.
MCF
| $415K | ﹤0.01% |
11,300
-11,600
| -51% | -$437K |
2013 Q2
1 quarter
|
|
|
DST
3896
CALL
DELISTED
DST Systems Inc.
DST
| $415K | ﹤0.01% |
11,000
-1,400
| -11% | -$50.5K |
2013 Q2
1 quarter
|
|
3897
Pacira BioSciences
PCRX
$1B
| $414K | ﹤0.01% |
8,606
+6,234
| +263% | +$227K |
2013 Q2
1 quarter
|
|
|
ACAT
3898
DELISTED
Arctic Cat Inc
ACAT
| $414K | ﹤0.01% |
+7,259
| New | +$395K |
2013 Q3
0 quarters
|
|
|
ZQK
3899
PUT
DELISTED
QUICKSILVER,INC.
ZQK
| $414K | ﹤0.01% |
58,900
+32,400
| +122% | +$202K |
2013 Q2
1 quarter
|
|
|
NP
3900
DELISTED
Neenah, Inc. Common Stock
NP
| $413K | ﹤0.01% |
10,510
-13,406
| -56% | -$505K |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.